EYPT
Eyepoint Pharmaceuticals Inc
3.60$
-0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 1,350.9% | 53.0% | 563.4% | 944.8% | 1,602.6% | 457.6% | 358.3% | 666.4% | 1,282.5% | 171.1% | 16.4% | 9.8% | 13.0% | 15.3% | 13.1% | 12.2% | 12.0% | 34.5% | 19.0% | 21.4% | 20.1% | 26.3% | 19.1% | 15.0% | 14.0% | 32.4% | 8.3% | 19.7% | 7.9% | 7.1% | 6.5% | 14.8% | 7.0% | 7.0% | 3.3% | 3.1% | 74.6% | 60.5% | 75.9% | 0.0% | 58.2% | |
| -1,250.9% | 47.0% | -463.4% | 100.0% | 100.0% | -357.6% | -258.3% | -566.4% | -1,182.5% | -71.1% | 83.6% | 90.2% | 87.0% | 84.7% | 86.9% | 87.8% | 88.0% | 65.5% | 81.0% | 78.6% | 79.9% | 73.7% | 80.9% | 85.0% | 86.0% | 67.6% | 91.7% | 80.3% | 92.1% | 92.9% | 93.5% | 85.2% | 93.0% | 93.0% | 96.7% | 96.9% | 25.4% | 39.5% | 24.1% | 100.0% | 41.8% | |
| 1,508.3% | 53.0% | 563.4% | 601.0% | 991.9% | 457.6% | 358.3% | 666.4% | 1,282.5% | 171.1% | 188.7% | 54.9% | 138.9% | 47.9% | 64.8% | 79.5% | 26.1% | 73.0% | 74.8% | 62.2% | 93.8% | 77.3% | 107.0% | 112.3% | 111.5% | 147.6% | 177.2% | 172.8% | 114.2% | 128.0% | 258.0% | 314.7% | 280.7% | 374.3% | 239.5% | 1,040.7% | 4,943.5% | 9,550.6% | 10,366.1% | 16,491.9% | 9,420.2% | |
| 1,185.9% | 48.6% | 411.2% | 374.3% | 668.1% | 265.0% | 245.8% | 590.2% | 856.2% | 194.1% | 229.1% | 66.8% | 174.0% | 48.1% | 58.2% | 116.3% | 36.9% | 81.0% | 69.8% | 57.5% | 66.9% | 79.8% | 92.0% | 74.0% | 92.0% | 80.7% | 120.3% | 99.5% | 69.4% | 80.2% | 120.7% | 134.5% | 123.2% | 108.6% | 56.7% | 222.4% | 1,500.0% | 1,835.8% | 2,190.1% | 2,809.1% | 1,984.8% | |
| 1,343.3% | 48.6% | 411.2% | 975.3% | 1,660.0% | 265.0% | 604.1% | 1,468.1% | 2,888.9% | 379.5% | 811.8% | 231.2% | 647.3% | 188.7% | 239.7% | 358.4% | 100.5% | 244.1% | 230.3% | 200.4% | 248.9% | 230.1% | 277.6% | 251.2% | 269.7% | 482.8% | 372.2% | 330.3% | 186.8% | 209.5% | 378.7% | 449.7% | 404.2% | 483.4% | 296.4% | 1,263.7% | 6,446.2% | 11,385.5% | 12,556.6% | 19,307.1% | 11,407.0% | |
| -2,594.2% | -1.6% | -874.6% | -875.3% | -1,560.0% | -622.5% | -504.1% | -1,368.1% | -2,788.9% | 550.7% | -728.2% | -141.0% | -560.4% | -104.1% | -152.8% | -270.5% | -12.5% | -178.6% | -149.3% | -121.8% | -169.0% | -156.4% | -196.7% | -166.2% | -183.8% | -415.2% | -280.5% | -250.0% | -94.7% | -116.6% | -285.2% | -364.5% | -311.2% | -390.4% | -199.7% | -1,166.8% | -6,420.8% | -11,346.0% | -12,532.5% | -19,207.1% | -11,365.2% | |
| 0.0% | 0.0% | 0.0% | 102.7% | 0.0% | 77.2% | 77.6% | 100.7% | 167.7% | 33.9% | 50.7% | 22.2% | 70.5% | 20.7% | 23.8% | 43.8% | 11.7% | 25.6% | 18.4% | 15.3% | 15.3% | 12.0% | 12.8% | 4.8% | 6.6% | 7.4% | 10.6% | 4.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | – | – | – | – | – | – | – | |
| -2,585.6% | -1.1% | -871.2% | -872.5% | -1,554.0% | -619.7% | -751.9% | -4,815.1% | -6,816.0% | -474.8% | -956.2% | -159.5% | -623.6% | -120.6% | -175.9% | -314.2% | -24.2% | -216.9% | -167.7% | -111.1% | -184.3% | -168.3% | -225.7% | -167.8% | -184.0% | -412.5% | -275.5% | -251.7% | -83.0% | -99.9% | -250.6% | -325.3% | -279.0% | -356.5% | -184.8% | -1,112.6% | -6,183.4% | -10,874.7% | -12,195.7% | -18,633.1% | -10,989.9% | |
| -68.2% | -3.5% | -34.9% | -30.5% | 0.0% | -24.4% | 247.8% | 9.0% | 32.3% | 0.0% | 50.7% | 3.7% | 7.3% | 4.2% | 0.7% | 0.2% | -0.3% | 25.6% | – | 15.3% | 0.1% | 12.0% | 16.8% | 3.1% | 0.2% | 196.5% | 5.5% | -13.0% | 12.0% | 0.6% | 0.0% | – | – | 0.8% | – | 1.7% | – | -30.0% | 7.2% | – | – | |
| -2,585.6% | -1.1% | -871.2% | -872.5% | -1,554.0% | -619.7% | -751.9% | -4,815.1% | -6,816.0% | -474.8% | -956.2% | -159.5% | -623.6% | -120.6% | -175.9% | -314.2% | -24.2% | -216.9% | -167.7% | -111.1% | -184.3% | -168.3% | -225.7% | -167.8% | -184.0% | -412.5% | -275.5% | -251.7% | -83.0% | -100.5% | -250.6% | -325.3% | -279.0% | -357.3% | -184.8% | -1,114.3% | -6,183.4% | -10,904.7% | -12,188.5% | -18,633.1% | -10,994.7% | |
| -2,517.3% | 1.9% | -839.7% | -841.9% | -1,496.6% | -598.1% | -499.5% | -1,276.4% | -2,653.5% | 550.7% | -872.7% | -128.3% | -527.3% | -92.4% | -144.2% | -254.1% | -8.3% | -181.9% | -139.9% | -88.2% | -162.2% | -150.3% | -205.4% | -156.9% | -170.3% | -401.9% | -263.5% | -245.5% | -82.2% | -99.1% | -248.0% | -321.5% | -275.1% | -352.3% | -182.8% | -1,102.5% | -6,123.8% | -9,332.7% | -12,104.3% | -18,371.6% | -10,556.1% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.